At first, scientists had no idea what might cause Alzheimer’s disease and had no underlying protein or pathway to target with treatments. Then came…
Since their discovery in the 1960s, stem cells have captivated our curiosity. Unlike other cells in the body, stem cells are changeable — they…
What happens when Alzheimer’s — a disease that strikes minority communities the hardest — is largely studied in well-educated whites? Is Alzheimer’s research one-size-fits…
Anti-amyloid drugs like Leqembi and Kisunla are among the first FDA-approved treatments for early-stage Alzheimer’s disease. But these breakthroughs come with a tradeoff: Up…
The Alzheimer’s Association’s latest “Facts and Figures” report finds most Americans want early screening and access to disease-modifying drugs — even at high cost…
Most older adults would prefer to age in place, but many rely on paid caregivers to make it work, according to a recent study…
Global context for this story: In a couple countries around the world so far, the conversation is beginning to shift as to whether people…
Many people with Alzheimer’s disease first lose neurons in their medial temporal lobe — a region of the brain involved in memory, navigation, emotional…